메뉴 건너뛰기




Volumn 59, Issue 6, 2000, Pages 1261-1277

Neuroblastoma: Current drug therapy recommendations as part of the total treatment approach

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; ANTIINFECTIVE AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; IFOSFAMIDE; IRINOTECAN; MELPHALAN; MESNA; MITOXANTRONE; PLATINUM DERIVATIVE; RETINOIC ACID; TENIPOSIDE; THIOTEPA; TIOGUANINE; TOPOTECAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCRISTINE; VINDESINE; ZILASCORB;

EID: 0034053718     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200059060-00006     Document Type: Review
Times cited : (108)

References (56)
  • 1
    • 0027239723 scopus 로고
    • Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment
    • 1. Brodeur GM, Prichard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11: 1466-77
    • (1993) J Clin Oncol , vol.11 , pp. 1466-1477
    • Brodeur, G.M.1    Prichard, J.2    Berthold, F.3
  • 2
    • 0029977194 scopus 로고    scopus 로고
    • Role of ploidy, chromosome 1p, and schwann cells in the maturation of neuroblastoma
    • 2. Ambros IM, Zellner A, Roald B, et al. Role of ploidy, chromosome 1p, and schwann cells in the maturation of neuroblastoma. N Engl J Med 1996; 334: 1505-11
    • (1996) N Engl J Med , vol.334 , pp. 1505-1511
    • Ambros, I.M.1    Zellner, A.2    Roald, B.3
  • 4
    • 0345294452 scopus 로고    scopus 로고
    • Neuroblastoma in Europe: Differences in the pattern of disease in the UK
    • 4. Powell JE, Estève J, Mann JR, et al. Neuroblastoma in Europe: differences in the pattern of disease in the UK. Lancet 1998; 352: 682-7
    • (1998) Lancet , vol.352 , pp. 682-687
    • Powell, J.E.1    Estève, J.2    Mann, J.R.3
  • 5
    • 0031417490 scopus 로고    scopus 로고
    • The current contribution of molecular factors in risk estimation in neuroblastoma patients
    • 5. Berthold F, Sahin K, Christiansen H, et al. The current contribution of molecular factors in risk estimation in neuroblastoma patients. Eur J Cancer 1997; 33: 2092-7
    • (1997) Eur J Cancer , vol.33 , pp. 2092-2097
    • Berthold, F.1    Sahin, K.2    Christiansen, H.3
  • 6
    • 0028181863 scopus 로고
    • Multivariate evaluation of prognostic factors in localized neuroblastoma
    • 6. Berthold F, Kassenböhmer R, Zischang J. Multivariate evaluation of prognostic factors in localized neuroblastoma. Am J Pediatr Hematol Oncol 1994; 16: 107-15
    • (1994) Am J Pediatr Hematol Oncol , vol.16 , pp. 107-115
    • Berthold, F.1    Kassenböhmer, R.2    Zischang, J.3
  • 7
    • 0013656729 scopus 로고    scopus 로고
    • Evaluation of catecholamine metabolites, mIBG scan and bone marrow cytology as response markers in stage 4 neuroblastoma
    • In press
    • 7. Hero B, Hunneman DH, Gahr M, et al. Evaluation of catecholamine metabolites, mIBG scan and bone marrow cytology as response markers in stage 4 neuroblastoma. Med Pediatr Oncol. In press
    • Med Pediatr Oncol
    • Hero, B.1    Hunneman, D.H.2    Gahr, M.3
  • 8
    • 0022388606 scopus 로고
    • Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas
    • 8. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985; 313: 1111-6
    • (1985) N Engl J Med , vol.313 , pp. 1111-1116
    • Seeger, R.C.1    Brodeur, G.M.2    Sather, H.3
  • 9
    • 0031727309 scopus 로고    scopus 로고
    • Prognostic significance of MYCN oncogene expression in childhood Neuroblastoma
    • 9. Bordow SB, Norris MD, Haber PS, et al. Prognostic significance of MYCN oncogene expression in childhood Neuroblastoma. J Clin Oncol 1998; 16: 3286-94
    • (1998) J Clin Oncol , vol.16 , pp. 3286-3294
    • Bordow, S.B.1    Norris, M.D.2    Haber, P.S.3
  • 10
    • 0026538759 scopus 로고
    • Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas
    • 10. Carlsen N, Ørnvold K, Christensen IJ, et al. Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas. Virchows Arch A Pathol Anat Histopathol 1992; 420: 411-8
    • (1992) Virchows Arch A Pathol Anat Histopathol , vol.420 , pp. 411-418
    • Carlsen, N.1    ØRnvold, K.2    Christensen, I.J.3
  • 11
    • 0025979843 scopus 로고
    • Clinical relevance of tumor cell ploidy and N.myc gene amplification in childhood neuroblastoma: A pediatric oncology group study
    • 11. Look AT, Hayes A, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N.myc gene amplification in childhood neuroblastoma: a pediatric oncology group study. J Clin Oncol 1991; 9: 581-91
    • (1991) J Clin Oncol , vol.9 , pp. 581-591
    • Look, A.T.1    Hayes, A.2    Shuster, J.J.3
  • 12
    • 0023835841 scopus 로고
    • Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma
    • 12. Christiansen H, Lampert F. Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Br J Cancer 1988; 57: 121-6
    • (1988) Br J Cancer , vol.57 , pp. 121-126
    • Christiansen, H.1    Lampert, F.2
  • 13
    • 13344275864 scopus 로고    scopus 로고
    • Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma
    • 13. Caron H, van Sluis P, de Kraker J, et al. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 1996; 334: 225-30
    • (1996) N Engl J Med , vol.334 , pp. 225-230
    • Caron, H.1    Van Sluis, P.2    De Kraker, J.3
  • 14
    • 0028790325 scopus 로고
    • The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma
    • 14. Gehring M, Berthold F, Edler L, et al. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma. Cancer Res 1995; 55: 5366-9
    • (1995) Cancer Res , vol.55 , pp. 5366-5369
    • Gehring, M.1    Berthold, F.2    Edler, L.3
  • 15
    • 0028023048 scopus 로고
    • Translocation involving 1p and 17q is a recurrent genetic alteration of human Neuroblastoma cells
    • 15. Savelyeva L, Corvi R, Schwab M. Translocation involving 1p and 17q is a recurrent genetic alteration of human Neuroblastoma cells. Am J Hum Genet 1994; 55: 334-40
    • (1994) Am J Hum Genet , vol.55 , pp. 334-340
    • Savelyeva, L.1    Corvi, R.2    Schwab, M.3
  • 16
    • 0028944776 scopus 로고
    • Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma
    • 16. Caron H. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med Pediatr Oncol 1995; 24: 215-21
    • (1995) Med Pediatr Oncol , vol.24 , pp. 215-221
    • Caron, H.1
  • 17
    • 0030031845 scopus 로고    scopus 로고
    • Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma
    • 17. Norris MD, Bordow SB, Marshall GM, et al. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med 1996; 334: 231-8
    • (1996) N Engl J Med , vol.334 , pp. 231-238
    • Norris, M.D.1    Bordow, S.B.2    Marshall, G.M.3
  • 18
    • 84993876589 scopus 로고
    • Correlating telomerase activity levels with human neuroblastoma outcomes
    • 18. Hiyama E, Hiyama K, Yokoyama T, et al. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995; 1: 249-55
    • (1995) Nat Med , vol.1 , pp. 249-255
    • Hiyama, E.1    Hiyama, K.2    Yokoyama, T.3
  • 19
    • 0033083005 scopus 로고
    • The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors
    • 19. Maitra A, Yashima K, Rathi A, et al. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Cancer 1991; 85: 741-9
    • (1991) Cancer , vol.85 , pp. 741-749
    • Maitra, A.1    Yashima, K.2    Rathi, A.3
  • 20
    • 0027285262 scopus 로고
    • Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in Neuroblastoma with favorable prognosis
    • 20. Kogner P, Barbany G, Dominici C, et al. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in Neuroblastoma with favorable prognosis. Cancer Res 1993; 53: 2044-50
    • (1993) Cancer Res , vol.53 , pp. 2044-2050
    • Kogner, P.1    Barbany, G.2    Dominici, C.3
  • 21
    • 0027531016 scopus 로고
    • Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma
    • 21. Nakagawara A, Arima-Nakagawara M, Scavarda N, et al. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 1993; 328: 847-54
    • (1993) N Engl J Med , vol.328 , pp. 847-854
    • Nakagawara, A.1    Arima-Nakagawara, M.2    Scavarda, N.3
  • 22
    • 0028011502 scopus 로고
    • Absence of CD44-standard in human neuroblastoma correlates with histological dedifferentiation, N-myc amplification and reduced survival probability
    • 22. Terpe HJ, Christiansen H, Berthold F, et al. Absence of CD44-standard in human neuroblastoma correlates with histological dedifferentiation, N-myc amplification and reduced survival probability. Cell Death Differ 1994; 1: 123-8
    • (1994) Cell Death Differ , vol.1 , pp. 123-128
    • Terpe, H.J.1    Christiansen, H.2    Berthold, F.3
  • 23
    • 0031427274 scopus 로고    scopus 로고
    • Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma
    • 23. Combaret V, Gross N, Lasset C, et al. Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma. Eur J Cancer 1997; 33: 2101-5
    • (1997) Eur J Cancer , vol.33 , pp. 2101-2105
    • Combaret, V.1    Gross, N.2    Lasset, C.3
  • 24
    • 0002976297 scopus 로고    scopus 로고
    • Sind Spontanregressionen beim Neuroblastom verspätete embryofetale Involutionen?
    • Heim ME, Schwarz R, editors. Stuttgart: Schattauer Verlag
    • 24. Berthold F, Hero B, Jobke A, et al. Sind Spontanregressionen beim Neuroblastom verspätete embryofetale Involutionen? In: Heim ME, Schwarz R, editors. Spontanremissionen bei krebserkrankungen. Stuttgart: Schattauer Verlag, 1998: 84-94
    • (1998) Spontanremissionen Bei Krebserkrankungen , pp. 84-94
    • Berthold, F.1    Hero, B.2    Jobke, A.3
  • 25
    • 0030597499 scopus 로고    scopus 로고
    • A population-based study of the usefulness of screening for neuroblastoma
    • 25. Woods WG, Tuchman M, Robison LL, et al. A population-based study of the usefulness of screening for neuroblastoma. Lancet 1996; 348: 1682-7
    • (1996) Lancet , vol.348 , pp. 1682-1687
    • Woods, W.G.1    Tuchman, M.2    Robison, L.L.3
  • 26
    • 0016687593 scopus 로고
    • Differentiation of neuroblastoma cells in culture
    • 26. Prasad KN. Differentiation of neuroblastoma cells in culture. Biol Rev Camb Philos Soc 1975; 50: 129-65
    • (1975) Biol Rev Camb Philos Soc , vol.50 , pp. 129-165
    • Prasad, K.N.1
  • 27
    • 0029004432 scopus 로고
    • Antiproliferative potential of cytostatic drugs on neuroblastoma cells in vitro
    • 27. Fulda S, Honer M, Menke-Moellers I, et al. Antiproliferative potential of cytostatic drugs on neuroblastoma cells in vitro. Eur J Cancer 1995; 31A: 616-21
    • (1995) Eur J Cancer , vol.31 A , pp. 616-621
    • Fulda, S.1    Honer, M.2    Menke-Moellers, I.3
  • 28
    • 0003154954 scopus 로고    scopus 로고
    • Treatment of advanced neuroblastoma: The european experience
    • Brodeur GM, Sawada T, Tsuchida Y, et al, editors. Amsterdam: Elsevier Press
    • 28. Hartmann O, Berthold F. Treatment of advanced neuroblastoma: the european experience, In: Brodeur GM, Sawada T, Tsuchida Y, et al, editors. Neuroblastoma. Amsterdam: Elsevier Press, 2000: 436-52
    • (2000) Neuroblastoma , pp. 436-452
    • Hartmann, O.1    Berthold, F.2
  • 29
    • 0013675406 scopus 로고    scopus 로고
    • Treatment of advanced neuroblastoma: The Japanese experience
    • Brodeur GM, Sawada T, Tsuchida Y, et al., editors. Amsterdam: Elsevier Press
    • 29. Tsuchida Y, Kaneko M. Treatment of advanced neuroblastoma: the Japanese experience, In: Brodeur GM, Sawada T, Tsuchida Y, et al., editors. Neuroblastoma. Amsterdam: Elsevier Press, 2000: 453-70
    • (2000) Neuroblastoma , pp. 453-470
    • Tsuchida, Y.1    Kaneko, M.2
  • 30
    • 0003154954 scopus 로고    scopus 로고
    • Treatment of advanced neuroblastoma: The U.S. experience
    • Brodeur GM, Sawada T, Tsuchida Y, et al., editors. Amsterdam: Elsevier Press
    • 30. Matthay KK, Castleberry RP. Treatment of advanced neuroblastoma: the U.S. experience. In: Brodeur GM, Sawada T, Tsuchida Y, et al., editors. Neuroblastoma. Amsterdam: Elsevier Press, 2000: 417-36
    • (2000) Neuroblastoma , pp. 417-436
    • Matthay, K.K.1    Castleberry, R.P.2
  • 31
    • 0020059019 scopus 로고
    • High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma
    • 31. Pritchard J, McElwain TJ, Graham-Pole J. High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br J Cancer 1982; 45: 86-94
    • (1982) Br J Cancer , vol.45 , pp. 86-94
    • Pritchard, J.1    McElwain, T.J.2    Graham-Pole, J.3
  • 32
    • 0033554684 scopus 로고    scopus 로고
    • Treatment of high risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation and 13-cis-retmoic acid
    • 32. Matthay K, Villablanca JG, Seeger RC, et al. Treatment of high risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation and 13-cis-retmoic acid. N Engl J Med 1999; 341: 1165-73
    • (1999) N Engl J Med , vol.341 , pp. 1165-1173
    • Matthay, K.1    Villablanca, J.G.2    Seeger, R.C.3
  • 33
    • 0031418315 scopus 로고    scopus 로고
    • Stage IV neuroblastoma in patients over 1 year of age at diagnosis: Consolidation of poor responders with combined busulfan, cyclophosphamide and melphalan followed by in vitro mafosfamide-purged autologous bone marrow transplantation
    • 33. Hartmann O, Valteau-Couanet D, Benhamou E, et al. Stage IV neuroblastoma in patients over 1 year of age at diagnosis: consolidation of poor responders with combined busulfan, cyclophosphamide and melphalan followed by in vitro mafosfamide-purged autologous bone marrow transplantation. Eur J Cancer 1997; 33: 2126-9
    • (1997) Eur J Cancer , vol.33 , pp. 2126-2129
    • Hartmann, O.1    Valteau-Couanet, D.2    Benhamou, E.3
  • 34
    • 0031431549 scopus 로고    scopus 로고
    • 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of european experience and conclusions
    • 34. Philip T, Ladenstein R, Lasset C, et al. 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of european experience and conclusions. Eur J Cancer 1997; 33: 2130-5
    • (1997) Eur J Cancer , vol.33 , pp. 2130-2135
    • Philip, T.1    Ladenstein, R.2    Lasset, C.3
  • 35
    • 0032401845 scopus 로고    scopus 로고
    • Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy
    • 35. Keshelava N, Seeger RC, Groshen S, et al. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy. Cancer Res 1998; 58: 5396-405
    • (1998) Cancer Res , vol.58 , pp. 5396-5405
    • Keshelava, N.1    Seeger, R.C.2    Groshen, S.3
  • 36
    • 0025826599 scopus 로고
    • Expression of mdr-1/P-glycoprotein in human neuroblastoma
    • 36. Bates ES, Shieh CY, Tsokos M. Expression of mdr-1/P-glycoprotein in human neuroblastoma. Am J Pathol 1991; 139: 305-15
    • (1991) Am J Pathol , vol.139 , pp. 305-315
    • Bates, E.S.1    Shieh, C.Y.2    Tsokos, M.3
  • 37
    • 0031791723 scopus 로고    scopus 로고
    • Presence of classical multidrug resistance and P-glycoprotein expression in human neuroblastoma cells
    • 37. Kurowski C, Berthold F. Presence of classical multidrug resistance and P-glycoprotein expression in human neuroblastoma cells. Ann Oncol 1998; 9: 1009-14
    • (1998) Ann Oncol , vol.9 , pp. 1009-1014
    • Kurowski, C.1    Berthold, F.2
  • 38
    • 0030752603 scopus 로고    scopus 로고
    • The CD95 (APO-1/Fas) System mediates drug-induced apoptosis in neuroblastoma cells
    • 38. Fulda S, Sieverts H, Friesen C, et al. The CD95 (APO-1/Fas) System mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 1997; 57: 3823-9
    • (1997) Cancer Res , vol.57 , pp. 3823-3829
    • Fulda, S.1    Sieverts, H.2    Friesen, C.3
  • 39
    • 0013674783 scopus 로고    scopus 로고
    • Chemotherapy of neuroblastoma
    • Pochedly C, editor. Boca Raton (FL): CRC Press Inc.
    • 39. Castleberry RP. Chemotherapy of neuroblastoma. In: Pochedly C, editor. Neuroblastoma: tumor biology and therapy. Boca Raton (FL): CRC Press Inc., 1998: 306-16
    • (1998) Neuroblastoma: Tumor Biology and Therapy , pp. 306-316
    • Castleberry, R.P.1
  • 40
    • 0025758201 scopus 로고
    • Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma
    • 40. Cheung N-K, Heller G. Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma. J Clin Oncol 1991; 9: 1050-8
    • (1991) J Clin Oncol , vol.9 , pp. 1050-1058
    • Cheung, N.-K.1    Heller, G.2
  • 41
    • 0033950139 scopus 로고    scopus 로고
    • LMCE3 treatment strategy: Results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis
    • 41. Frappaz D, Michon J, Coze C, et al. LMCE3 treatment strategy: results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis. J Clin Oncol 2000; 18: 468-76
    • (2000) J Clin Oncol , vol.18 , pp. 468-476
    • Frappaz, D.1    Michon, J.2    Coze, C.3
  • 42
    • 0024579424 scopus 로고
    • Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy
    • 42. Matthay K, Sather H, Seeger R, et al. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 1989; 7: 236-44
    • (1989) J Clin Oncol , vol.7 , pp. 236-244
    • Matthay, K.1    Sather, H.2    Seeger, R.3
  • 43
    • 0029739031 scopus 로고    scopus 로고
    • Successful management of low-stage neuroblastoma without adjuvant therapies: A comparison of two decades, 1972 through 1981 and 1982 through 1992 in a single institution
    • 43. Evans A, Silber J, Shpilsky A, et al. Successful management of low-stage neuroblastoma without adjuvant therapies: a comparison of two decades, 1972 through 1981 and 1982 through 1992 in a single institution. J Clin Oncol 1997; 14: 2504-10
    • (1997) J Clin Oncol , vol.14 , pp. 2504-2510
    • Evans, A.1    Silber, J.2    Shpilsky, A.3
  • 44
    • 0002456398 scopus 로고
    • Risk factors in neuroblastoma of infants
    • Harms Diagnose, Huber H, Queisser W, editors. Basel: S. Karger AG
    • 44. Berthold F, Harms Diagnose, Lampert F, et al. Risk factors in neuroblastoma of infants, In: Huber H, Queisser W, editors. Contribution to oncology. Basel: S. Karger AG: 1990; 41: 101-17
    • (1990) Contribution to Oncology , vol.41 , pp. 101-117
    • Berthold, F.1    Lampert, F.2
  • 45
    • 0013654554 scopus 로고    scopus 로고
    • Neuroblastom
    • Schmoll H-J, Hoeffken K, Possinger K, editors. Berlin: Springer
    • 45. Berthold F. Neuroblastom. In: Schmoll H-J, Hoeffken K, Possinger K, editors. Kompendium internistische onkologie. Berlin: Springer, 1999: 2389-402
    • (1999) Kompendium Internistische Onkologie , pp. 2389-2402
    • Berthold, F.1
  • 46
    • 0033004953 scopus 로고    scopus 로고
    • Long-term outcome of patients with intraspinal neuroblastoma
    • 46. Hoover M, Bowman L, Crawford SE, et al. Long-term outcome of patients with intraspinal neuroblastoma. Med Pediatr Oncol 1999; 32: 353-9
    • (1999) Med Pediatr Oncol , vol.32 , pp. 353-359
    • Hoover, M.1    Bowman, L.2    Crawford, S.E.3
  • 47
    • 0025365117 scopus 로고
    • The role of chemotherapy in the treatment of children with neuroblastoma stage IV: The GPO (German Pediatric Oncology Society) experience
    • 47. Berthold F, Burdach S, Kremens B, et al. The role of chemotherapy in the treatment of children with neuroblastoma stage IV: the GPO (German Pediatric Oncology Society) experience. Klin Pädiatr 1990; 202: 262-9
    • (1990) Klin Pädiatr , vol.202 , pp. 262-269
    • Berthold, F.1    Burdach, S.2    Kremens, B.3
  • 48
    • 0032422239 scopus 로고    scopus 로고
    • Neuroblastoma and treatment-related myelodysplasia/leukemia: The memorial Sloan-Kettering experience and a literature review
    • 48. Kushner BH, Cheung N-K, Kramer K, et al. Neuroblastoma and treatment-related myelodysplasia/leukemia: the memorial Sloan-Kettering experience and a literature review. J Clin Oncol 1998; 16: 3880-9
    • (1998) J Clin Oncol , vol.16 , pp. 3880-3889
    • Kushner, B.H.1    Cheung, N.-K.2    Kramer, K.3
  • 49
    • 0030854884 scopus 로고    scopus 로고
    • Positive selection and transplantation of peripheral CD34+ progenitor cells: Feasibility and purging efficacy in pediatric patients with neuroblastoma
    • 49. Handgretinger R, Greil J, Schurmann U, et al. Positive selection and transplantation of peripheral CD34+ progenitor cells: feasibility and purging efficacy in pediatric patients with neuroblastoma. J Hematother 1997; 6: 235-42
    • (1997) J Hematother , vol.6 , pp. 235-242
    • Handgretinger, R.1    Greil, J.2    Schurmann, U.3
  • 50
    • 0344654819 scopus 로고    scopus 로고
    • Neuroblastoma cells can express the hematopoietic cell antigen CD34 as detected at surface protein an mRNA level
    • 50. Hafer R, Voigt A, Gruhn B, et al. Neuroblastoma cells can express the hematopoietic cell antigen CD34 as detected at surface protein an mRNA level. J Neuroimmunol 1999; 96: 201-6
    • (1999) J Neuroimmunol , vol.96 , pp. 201-206
    • Hafer, R.1    Voigt, A.2    Gruhn, B.3
  • 51
    • 0023025419 scopus 로고
    • Magnetic microspheres an monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: Experiences, improvements and observations
    • 51. Kemshead JT, Heath L, Gibson FM, et al. Magnetic microspheres an monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations. Br J Cancer 1986; 54: 771-8
    • (1986) Br J Cancer , vol.54 , pp. 771-778
    • Kemshead, J.T.1    Heath, L.2    Gibson, F.M.3
  • 52
    • 0013695806 scopus 로고    scopus 로고
    • Increased incidence of secone leukemia after maintenance chemotherapy in neuroblastoma patients
    • 52. Hero B, Niemeyer C, Dörffel W, et al. Increased incidence of secone leukemia after maintenance chemotherapy in neuroblastoma patients [abstract]. Med Pediatr Oncol 1996; 27: 303
    • (1996) Med Pediatr Oncol , vol.27 , pp. 303
    • Hero, B.1    Niemeyer, C.2    Dörffel, W.3
  • 53
    • 7144262406 scopus 로고    scopus 로고
    • An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma
    • 53. Michon JM, Hartmann O, Bouffet E, et al. An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma. Eur J Cancer 1998; 34: 1063-9
    • (1998) Eur J Cancer , vol.34 , pp. 1063-1069
    • Michon, J.M.1    Hartmann, O.2    Bouffet, E.3
  • 54
    • 0030683515 scopus 로고    scopus 로고
    • Stem cell factor suppresses apoptosis in neuroblastoma cell lines
    • 54. Timeus F, Crescenzio N, Valle P, et al. Stem cell factor suppresses apoptosis in neuroblastoma cell lines. Exp Hematol 1997; 25 : 1253-60
    • (1997) Exp Hematol , vol.25 , pp. 1253-1260
    • Timeus, F.1    Crescenzio, N.2    Valle, P.3
  • 55
    • 0003225107 scopus 로고    scopus 로고
    • Experimental therapeutics and new agents for neuroblastoma
    • Brodeur GM, Sawada T, Tsuchida Y, et al., editors. Amsterdam: Elsevier Press
    • 55. Vassal G, Pinkerton R. Experimental therapeutics and new agents for neuroblastoma. In: Brodeur GM, Sawada T, Tsuchida Y, et al., editors. Neuroblastoma. Amsterdam: Elsevier Press, 2000: 383-92
    • (2000) Neuroblastoma , pp. 383-392
    • Vassal, G.1    Pinkerton, R.2
  • 56
    • 0031934032 scopus 로고    scopus 로고
    • Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumor: A pediatric oncology group study
    • 56. Saylors R, Stewart C, Zamboni W, et al. Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumor: a pediatric oncology group study. J Clin Oncol 1998; 16: 945-52
    • (1998) J Clin Oncol , vol.16 , pp. 945-952
    • Saylors, R.1    Stewart, C.2    Zamboni, W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.